Constellation Bra (STZ) Offering Possible 35.14% Return Over the Next 9 Calendar Days

Constellation Bra's most recent trend suggests a bullish bias. One trading opportunity on Constellation Bra is a Bull Put Spread using a strike $141.00 short put and a strike $136.00 long put offers a potential 35.14% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $141.00 by expiration. The full premium credit of $1.30 would be kept by the premium seller. The risk of $3.70 would be incurred if the stock dropped below the $136.00 long put strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Constellation Bra is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Constellation Bra is bearish.

The RSI indicator is at 59.95 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Constellation Bra

Constellation Brands CEO Says Alcohol Company Had 'Superb' March
Mon, 06 Apr 2020 18:41:54 +0000
Alcohol company Constellation Brands, Inc. (NYSE: STZ) is seeing a minimal impact to sales from the coronavirus, as shutdowns work to "our advantage," CEO Bill Newlands told CNBC "Mad Money" host Jim Cramer in a Friday interview.'Superb' March For Constellation One would assume that the vast number of restaurants and bar closures would impact alcohol sales, but that isn't the case at all, Newlands said.March "has been superb" due to a channel shift as the on-premise restaurant and bar channel closes, he said. But the public can so far purchase alcohol for consumption at home, as governments declare alcohol to be an essential product."Given that 85% to 90% of our business across all three sectors is done in the off premise, it really works to our advantage, to some degree," Newlands said.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Constellation Holds Back On Full-Year Guidance Despite a strong performance throughout March, Constellation feels it is too "risky" at this time to offer full-year guidance, the CEO said.It is unclear to what March's sales will reflect "pantry loading," he said. This would be consistent with what is seen in recessionary periods, although this time around, the coronavirus represents "uncharted waters," Newlands said. Once management has a better understanding of "how things are going to work out," it can then offer an outlook, he said.What's Next For Constellation Consumers shouldn't worry that their supermarkets and grocery stores will run out of Corona beer or other brands, Newlands said, adding that the company remains committed to supplying consumer demand moving forward.The stock was trading 7.22% higher at $141.71 at the time of publication Monday. Related Links:Alcohol Sales Up 55% In Third Week Of MarchThe Story Behind The Ticker: Constellation BrandsSee more from Benzinga * Rough Draft: 4 Growing Trends In Craft Beer(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Goldman Sachs: 3 Beverage Stocks to Stock Up on Now
Mon, 06 Apr 2020 14:47:03 +0000
“To say the world has completely changed over the last 1-2 months in the wake of the COVID-19 pandemic is an understatement,” says Goldman Sachs’ Bonnie Herzog in a recent note to clients. It is impossible to disagree. Wall Street has been grappling with the implications, as stock prices and valuations have tumbled due to the increased uncertainty in the face of COVID-19’s long term impact.Herzog has been assessing the current health of the beverage and tobacco sector, and in addition to the “unprecedented uncertainty” regarding the broader economy, is worried of other possible developments.“We are also concerned about the ripple effect on broader consumer demand as concerns about health considerations & social distancing give way to the long-term effects on the job market, wages, consumer behavior & consumer spending,” Herzog said.Having said that, the analyst identifies a number of names in the beverage sector that are well setup to outperform as the year progresses.We ran three of Goldman Sachs' top picks through TipRanks’ database to further gauge Street sentiment towards them. As it happens, all are Buy rated, and what’s more, the analysts forecast all to have at least 25% upside in the year ahead. Let’s take a closer look.Boston Beer Company (SAM)Let’s start off with one of 2020’s sturdier performers in the face of COVID-19. Although the Boston Beer Company’s share price is down by 5% year-to-date, it has fared significantly better than the overall market, considering the S&P 500’s 20% decline.There are a couple of reasons, according to Herzog, why the company has proved resilient. SAM’s relative lack of exposure to the on-premise channel, compared to its peers, means it has taken less of a hit from the nationwide closure of bars and restaurants. 11% of SAM’s business is on premises, compared to the industry average of 16%. Furthermore, the reduction of on-premise sells is set to be countered by a strong retail/take home trend.The second positive driver for SAM is due to it being “advantageously levered” to what Herzog claims is “one of the few ‘big’ growth opportunities in alcoholic beverages,” – hard seltzers. In its brand Truly, SAM has the No.2 position in the hard seltzer market, which the analyst believes, it is not about to relinquish any time soon.The trend, Herzog argues, is only likely to grow. The analsyt said, “We believe the hard seltzer category is here to stay and our analysis suggests category volumes could expand 2-3x by 2023 to become ~10% of total beer consumption in the U.S., up from ~3.5% in 2019. As a strong No.2, we believe Truly could capture a significant share of this growth and our sensitivity analysis suggests every incremental 6% step-up in Truly shipment volume growth boosts SAM’s net rev growth by +340bps.”To this end, Herzog resumes coverage of SAM with a Buy rating along with a $415 price target. The upside from current levels is 13%. (To watch Herzog’s track record, click here)Turning now to the rest of the Street, SAM has a Strong Buy consensus rating, based on 7 Buys and 2 Holds. At $450, the average price target is set to provide upside of 24%, should it be met in the year ahead. (See SAM stock analysis on TipRanks)Constellation Brands Inc (STZ)Unlike SAM, Constellation Brands can’t boast of beating the market so far in 2020. The largest beer import company in the US is down by 30% since the turn of year. But like SAM, Herzog sees multiple growth drivers for Constellation, calling it “one of the most attractive stocks across consumer staples and among the rare ones levered to growth.”Herzog argues STZ’s valuation has been unfairly punished due to the coronavirus’s impact on on-premise business (roughly 15% of the company’s beer sales) and an overreaction to its exposure to California, where stay-at-home measures have been implemented since mid-March, and, therefore, impacting sales.But There is another problem that has just reared its ugly head for Constellation. The company owns Grupo Modelo’s – the maker of Corona beer – U.S. rights. Unlike in the U.S., beer is not considered an essential business in Mexico and Anheuser-Bush InBev, who own Modelo’s rest of the world’s rights, temporarily shut down its Mexican brewing facilities on Sunday April 5th, to help curb the spread of the virus. Constellation Brands’ CEO Bill Newlands has said the company’s Mexico plants are still operating and it has 70 days of inventory to guarantee minimal disruption, but with uncertainty currently in the air, it will be interesting to see if the plants remain open for much longer.Nevertheless, Herzog is confident in Constellation’s long-term growth drivers. The analyst said, “We believe STZ can deliver on its growth objectives without significant degradation to its beer operating margin, which at ~39% is already very high and best-in-class. We believe, like the best CPG operators out there, STZ has multiple levers to pull to drive top-line growth while protecting profits/margins, and we expect this to happen as the company “leans into change” and leads on growth.”Therefore, coverage on Constellation is resumed, with a Buy rating and a $165 price target, implying possible upside of 17%.Overall, 10 Buys and 6 Hold ratings published over the last 3 months present STZ with a Moderate Buy consensus rating. The average price target comes in at $192.07, and suggests possible upside of 37%. (See Constellation Brands stock analysis on TipRanks)Monster Beverage Corp (MNST)The last name on our list nestles somewhere between our two previous companies. With a 15% year-to-date drop, according to Herzog, the manufacturer of energy drinks including Monster Energy, Relentless and Burn is well set up to reward investors. “Simply put,” Herzog says, “We see recent share price pressure as a buying opportunity.”Herzog believes “strong customer loyalty & low household penetration” are reasons why the energy category “will remain resilient in the current climate.”And according to optimistic comments from the analyst’s convenience store retailer contacts, concerns about significant less demand across the category due to COVID-19’s impact on lower traffic, are “misplaced.” Additionally, energy drink consumers are likely to step up purchases in other channels and load up on pantry items.“In short,” Herzog concludes “we think this is being largely disregarded by the market, with shares trading at a FY21 P/E multiple of 23.5x, an -12% discount vs. MNST 1-year historical average multiple of 26.5x and a -19% discount vs. MNST’s 3-year historical average multiple of 28.9x. Most importantly, MNST’s current valuation only implies an 85% premium vs. the S&P 500 (slightly below MNST’s 5-year average premium of 86%) despite limited downside risk to growth, improving margins & an increasingly rational competitive environment.”Bottom line, what does it mean for investors? Herzog resumes coverage with a Buy rating and a $65 price target. Expects returns in the shape of 20%, should the analyst’s thesis play out in the coming months.Looking at the consensus breakdown, 7 Buys, 3 Holds and 1 Sell rating coalesce to a Moderate Buy consensus rating for the energy drink manufacturer. Investors will take home a 19% gain, should the average price target of $67.33, be met over the next year. (See Monster Beverage stock analysis on TipRanks)To find good ideas for beverage stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Liquor Stocks in Focus as Sales Surge
Mon, 06 Apr 2020 13:52:41 +0000
Alcoholic beverage sales jumped significantly in March. Explore three liquor stocks that should befit if the trend continues.

Constellation Brands Could Ride Market's Coattails
Mon, 06 Apr 2020 13:30:00 +0000
The maker of beer, wine and spirits could ignore its bearish clues and follow the broad market higher here on Monday.

Edited Transcript of STZ earnings conference call or presentation 3-Apr-20 3:30pm GMT
Mon, 06 Apr 2020 05:48:39 +0000
Q4 2020 Constellation Brands Inc Earnings Call

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.